Volume 61 Received 9 May 2005 | ||||||||||
| ||||||||||
aDepartment of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, England
Correspondence e-mail: d.a.tocher@ucl.ac.uk
The low-temperature structure determination of butyramide, C4H9NO, obtained as part of a experimental polymorph screen on adenine, is reported here. Each molecule takes part in four hydrogen bonds to form a three-dimensional ribbon structure.
The title compound, (I)
, is one of the n-aliphatic amides and has recently been studied as a possible agent for growth inhibition of human neuroblastoma cell lines (Rocchi et al., 1998
) and inhibitory effects on DNA synthesis on hepatoma cells (Lea et al., 1993
).
The powder diffractogram data for (I)
were reported in 1950 (Matthews et al., 1950
), as part of a study on derivatives of fatty acids, and the unit cell was determined five years later (Turner & Lingafelter, 1955
) using Weissenberg photographs, to give a = 9.94 Å, b = 5.79 Å, c = 10.02 Å and
= 100.9°. Examination of the systematic absences showed the space group to be P21/a; however, no atomic coordinates were published. We have solved and refined the crystal structure of butyramide at 150 K, to give a final R value of 0.041. There is a 12° difference in the
angle between the two determinations. In (I)
, the bond lengths and angles are within expected values (Allen et al., 1987
), with the C-C bond lengths in the range 1.5057 (18)-1.515 (2) Å and with N1-C1 and O2-C1 bond lengths of 1.3257 (15) and 1.2395 (13) Å, respectively. There is a relative twist of the carbon chain from planarity, with torsion angles C1-C2-C3-C4 and N1-C1-C2-C3 of 177.41 (21) and 151.62 (12)°, respectively. The packing consists of centrosymmetric dimers, linked through a pair of N-H
O hydrogen bonds [2.9470 (15) Å]. The other amine H atom is used to hydrogen bond to an adjacent dimer unit which is approximately perpendicular (73°), through an N-H
O hydrogen bond [2.8496 (14) Å], resulting in the formation of a three-dimensional criss-crossed ribbon structure (Fig. 2
).
| Figure 1 View of (I) , showing the atom labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. |
| Figure 2 The packing in (I) , showing the butyramide dimer unit which forms a hydrogen-bonded (dashed lines) criss-cross ribbon motif. |
As part of an experimental polymorph screen on adenine, (I)
was obtained from a 0.3 M aqueous solution of (I)
, to which approximately 0.15 g of adenine was added, and which was stirred on a hotplate at 303 K for 3 d. This solution was filtered, then evaporated at room temperature (10 ml solution, in 75 × 25 mm vessels) in an attempt to crystallize adenine, as it has been found that the solubility of purine and pyrimidine bases increases in aqueous amide solutions (Herskovits & Bowen, 1974
). Colourless block-like crystals of (I)
were formed after a number of days.
|
|
| ||||||||||||||||||||||
H atoms were refined independently with an isotropic model.
Data collection: SMART (Bruker, 2000
); cell refinement: SAINT; data reduction: SAINT (Bruker, 2000
); program(s) used to solve structure: SHELXS97 (Sheldrick, 1990
); program(s) used to refine structure: SHELXL97 (Sheldrick, 1997
); molecular graphics: SHELXTL (Bruker, 2000
) and MERCURY (Bruno et al., 2002
); software used to prepare material for publication: SHELXL97.
This research was supported by the EPSRC in funding a studentship for TCL. The authors acknowledge the Research Councils UK Basic Technology Programme for supporting `Control and Prediction of the Organic Solid State'. For more information on this work, please visit http://www.cposs.org.uk .
Allen, F. H., Kennard, O. & Watson, D. G. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-18.
Bruker (2000). SMART, SAINT and SHELXTL. Bruker AXS Inc., Madison, Wisconsin, USA.
Bruno, I. J., Cole, J. C., Edgington, P. R., Kessler, M. K., Macrae, C. F., McCabe, P., Pearson, J. & Taylor, R. (2002). Acta Cryst. B58, 389-397.
![[details]](../../../../../../b/graphics/details.gif)
Herskovits, T. T. & Bowen, J. J. (1974). Biochemistry, 13, 5474-5483.
![[ISI]](../../../../../../logos/isiborder.gif)
Lea, M. A., Xiao, Q., Sadhukhan, A., Sharma, S. & Newmark, H. L. (1993). Anticancer Res. 13, 145-150.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Matthews, F. W., Warren, G. G. & Michell, J. H. (1950). Anal. Chem. 22, 514-519.
![[ISI]](../../../../../../logos/isiborder.gif)
Rocchi, P., Ferreri, A. M., Magrini, E. & Perocco, P. (1998). Anticancer Res. 18, 1099-1103.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Sheldrick, G. M. (1990). Acta Cryst. A46, 467-473.
![[details]](../../../../../../a/graphics/details.gif)
Sheldrick, G. M. (1996). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (1997). SHELXL97. University of Göttingen, Germany.
Turner, J. D. & Lingafelter, E. C. (1955). Acta Cryst. 8, 549-550.
![[details]](../../../../../../q/graphics/details.gif)